Ranitidine Hydrochloride
- Product NDC
- 42291-735
- 11-digit product format
- 422910735
- Labeler code
- 42291
- Product ID
- 42291-735_b56a1119-3e79-6414-e053-2995a90a8105
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ranitidine Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- AvKARE, Inc.
- Application
- ANDA075742
- Marketing category
- ANDA
- Marketing start
- 2017-03-31
- Marketing end
- 0000-00-00
- Substance
- RANITIDINE HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42291-735-50 | 42291073550 | 500 CAPSULE in 1 BOTTLE (42291-735-50) | 500 capsule | 2017-03-31 | 0000-00-00 | No | No | Current |